212 related articles for article (PubMed ID: 2470188)
1. [Interferon therapy in urology].
Kriegmair M; Hofstetter A
Urologe A; 1989 Mar; 28(2):116-21. PubMed ID: 2470188
[TBL] [Abstract][Full Text] [Related]
2. The role of imaging in the surveillance of urologic malignancies.
Bradford TJ; Montie JE; Hafez KS
Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for metastatic renal cell carcinoma.
Wirth MP
Urol Clin North Am; 1993 May; 20(2):283-95. PubMed ID: 7684167
[TBL] [Abstract][Full Text] [Related]
5. Palliative care in urology.
Wu JN; Meyers FJ; Evans CP
Surg Clin North Am; 2011 Apr; 91(2):429-44, x. PubMed ID: 21419262
[TBL] [Abstract][Full Text] [Related]
6. Present status of cancer treatment in Singapore-management of urological cancers.
Tun KH; Tan EC; Foo KT
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1139-45. PubMed ID: 1514826
[No Abstract] [Full Text] [Related]
7. [Urologic tumors in old age].
Debruyne FM
Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):65-8. PubMed ID: 3715964
[TBL] [Abstract][Full Text] [Related]
8. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
9. [Interferons in the treatment of solid tumors. A general review].
Dorval T; Pouillart P
Bull Cancer; 1988; 75(9):885-8. PubMed ID: 2462946
[TBL] [Abstract][Full Text] [Related]
10. Open clinical uro-oncology trials in Canada.
Mackenzie M; Rodrigues G; Winquist E
Can J Urol; 2007 Aug; 14(4):3662-7. PubMed ID: 17784993
[No Abstract] [Full Text] [Related]
11. The systemic therapy of urologic cancer.
Marsh JC
Conn Med; 1980 Apr; 44(4):217-24. PubMed ID: 7371401
[No Abstract] [Full Text] [Related]
12. Gene therapy approaches in urologic oncology.
Vieweg J; Gilboa E
Surg Oncol Clin N Am; 1995 Apr; 4(2):203-18. PubMed ID: 7796281
[TBL] [Abstract][Full Text] [Related]
13. [Biological response modifiers and urological cancer].
Ohmori H; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1992 Jun; 83(6):850-6. PubMed ID: 1501395
[No Abstract] [Full Text] [Related]
14. An assessment of the current use of human interferons in therapy of urological cancers.
Horoszewicz JS; Murphy GP
J Urol; 1989 Nov; 142(5):1173-80. PubMed ID: 2478725
[No Abstract] [Full Text] [Related]
15. [Response criteria for urological cancer treatment].
Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):447-72. PubMed ID: 1593826
[No Abstract] [Full Text] [Related]
16. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
17. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
18. [Effect of recombinant alpha-interferon on advanced renal cell carcinoma].
Isaka S; Okano T; Akimoto S; Shimazaki J; Murakami S; Igarashi T; Kitamura Y; Yamaguchi K; Kataumi S; Ohtsuka K
Hinyokika Kiyo; 1985 Dec; 31(12):2209-14. PubMed ID: 3832921
[TBL] [Abstract][Full Text] [Related]
19. [Update on the medical treatment of urologic tumors].
Culine S
Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
[No Abstract] [Full Text] [Related]
20. Is cytotoxic chemotherapy effective in the treatment of advanced renal cell carcinoma?
Swanson DA
Semin Urol; 1993 Feb; 11(1):35-40. PubMed ID: 7682003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
